Search

everythinglearnresearchcommunity

for

Search:↓

Low-dose oral minoxidil can cause serious side effects like heart issues, so use the lowest effective dose.

Rivaroxaban may cause hair loss.

Tadalafil may reduce the risk of major heart events and blood clots in men with urinary symptoms.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

The combination of spironolactone and low-dose minoxidil is generally safe for treating hair loss in adult females, with mostly mild side effects.

Minoxidil helps lower high blood pressure in kids, but can cause fluid retention and hair growth.

UHP-sCESr is as effective as HESr for treating BPH symptoms.

A woman developed swelling in her body after taking low-dose oral minoxidil for hair loss, but it resolved after stopping the medication.

Low dose oral minoxidil can help with hair growth but may cause serious heart problems, so doctors need to be careful.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

These drugs raise prostaglandin-like material in dog blood, possibly causing blood vessel widening.

Montelukast is linked to increased risks of suicidal thoughts and depression.

Nitrendipine and nifedipine effectively block muscle contractions, while papaverine relaxes them and minoxidil needs high amounts to work.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Ginsenoside compound K shows promise for treating metabolic diseases like diabetes and obesity.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Minoxidil helps heart function but doesn't improve exercise ability and may cause complications.

Sorafenib can cause delayed skin problems, so patients need careful monitoring.

Digoxin is linked to a higher risk of anemia in patients with atrial fibrillation and heart failure.

Baricitinib may cause low blood sugar in some patients, so careful monitoring is needed.

The new delivery method for dutasteride is more effective and has fewer side effects.

Digital health technology improves health and medication adherence in kidney transplant patients.